SWAV vs. NVDA

Last updated Apr 1, 2026

Compare and contrast key facts about ShockWave Medical, Inc. (SWAV) and NVIDIA Corporation (NVDA).

Performance

SWAV vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ShockWave Medical, Inc. (SWAV) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

SWAV vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
SWAV ShockWave Medical, Inc.	0.00%	0.00%	75.67%	-7.32%	15.30%	71.93%	136.16%	44.00%
NVDA NVIDIA Corporation	-6.48%	38.92%	171.25%	239.02%	-50.26%	125.48%	122.30%	58.10%

Fundamentals

Total Revenue (TTM) SWAV : $787.97M NVDA : $215.94B
Gross Profit (TTM) SWAV : $685.44M NVDA : $153.46B
EBITDA (TTM) SWAV : $204.51M NVDA : $144.55B

Returns By Period

SWAV

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NVDA

• 1D: 5.59%
• 1M: -1.57%
• YTD: -6.48%
• 6M: -6.52%
• 1Y: 60.95%
• 3Y*: 84.54%
• 5Y*: 66.14%
• 10Y*: 69.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SWAV vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVDA

NVDA Risk / Return Rank: 83
NVDA Sharpe Ratio Rank: 85
NVDA Sortino Ratio Rank: 82
NVDA Omega Ratio Rank: 80
NVDA Calmar Ratio Rank: 86
NVDA Martin Ratio Rank: 85

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SWAV vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ShockWave Medical, Inc. (SWAV) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	SWAV	NVDA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.48	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.29	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.40	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.61	—

Correlation

The correlation between SWAV and NVDA is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SWAV vs. NVDA - Dividend Comparison

SWAV has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SWAV ShockWave Medical, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVDA NVIDIA Corporation	0.02%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Drawdowns

Drawdown Indicators

	SWAV	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	—	-89.72%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-20.21%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-66.34%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-66.34%	—
Current Drawdown Current decline from peak	—	-15.76%	—
Average Drawdown Average peak-to-trough decline	—	-36.40%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	7.99%	—

Volatility

Volatility by Period

	SWAV	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	10.46%	—
Volatility (6M) Calculated over the trailing 6-month period	—	25.91%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	41.44%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	51.74%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	49.85%	—

Financials